Zoetis (ZTS) cash: $2.5B
Zoetis held $2.5B in cash and cash equivalents on Dec 31, 2025, up 23.3% from $2B a year earlier.
From Zoetis's filings with the SEC · Read the filing · ZTS stock page
Zoetis cash by year
#240 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $2.5B | +23% |
| Dec 31, 2024 | $2B | -3% |
| Dec 31, 2023 | $2B | -43% |
| Dec 31, 2022 | $3.6B | +3% |
| Dec 31, 2021 | $3.5B | – |
Cash of similar companies
Companies in the same industry as Zoetis, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| TEVA Pharmaceutical Industries | $3.6B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $3.1B | Dec 31, 2025 |
| Zoetis | $2.5B | Dec 31, 2025 |
| Alnylam Pharmaceuticals | $1.7B | Dec 31, 2025 |
| United Therapeutics | $1.6B | Dec 31, 2025 |
| Roivant Sciences | $1.5B | Dec 31, 2025 |
| Jazz Pharmaceuticals | $1.4B | Dec 31, 2025 |
Questions and answers
What is Zoetis's cash?
Zoetis held $2.5B in cash and cash equivalents on Dec 31, 2025, up 23.3% from $2B a year earlier.
Numbers as reported in Zoetis's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology